Live feed
Filing
SC 13G/A
SC 13G/A0001072613-16-000576·ARCH Venture Fund VII, L.P.
Schedule 13G ownership disclosure
Juno Therapeutics, Inc.
Security class unavailable · CUSIP: 48205A109
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000576
- Form type
- SC 13G/A
- Filer
- ARCH Venture Fund VII, L.P.
- CIK
- CIK 1402439
- Filed
- Feb 11, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership